USD 11.83 Billion
Stem Cell Market Size, Share, Growth Analysis, By Product(Adult stem cells (ASCs) (Hematopoietic, Mesenchymal, Neural, Epithelial/Skin), By Application(Regenerative medicines (Neurology, Orthopaedics, Oncology, Haematology), By Technology(Cell acquisition (Bone marrow harvest, Umbilical blood cord, Apheresis), Cell Production (Therapeutic cloning), By Therapy(Autologous, Allogenic), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35D2059 |
Region:
Global |
Published Date: February, 2024
Pages:
275
|Tables:
138
|Figures:
77
Stem Cell Market Insights
Stem Cell Market size was valued at USD 11.83 Billion in 2019 and is poised to grow from USD 13.30 Billion in 2023 to USD 31.60 Billion by 2031, at a CAGR of 11.4% during the forecast period (2024-2031).
The global stem cell market is experiencing remarkable growth, driven by various factors and promising opportunities. The rising number of clinical trials and the growing adoption of stem cell therapies worldwide contribute significantly to market expansion. Additionally, in the context of COVID-19, government organizations, research institutes, and biotech and pharmaceutical firms are focusing on rapid and effective technologies for diagnosing and treating the disease. Stem cell therapies, such as mesenchymal stem cell-based immunomodulation treatment, have shown promise in treating COVID-19, leading to ongoing clinical trials. Positive results from these studies can pave the way for new therapies and fuel market growth. Furthermore, increased awareness about umbilical stem cells, growing demand for regenerative treatment options, and the pursuit of stem cell research and development initiatives are driving market growth. Companies are actively raising funds to develop stem cell-based therapies, highlighting the significant investments being made in this field. For example, Cellino Biotech raised USD 80 million to expand access to stem cell-based therapies and build a pioneering autonomous human cell foundry by 2031. The expanding applications of stem cell technologies and the higher adoption rates for these therapies globally are attracting increased investments from market players, further propelling the market growth.
Government initiatives that support research studies and provide funding also contribute to the market's expansion. Notably, the Australian Government allocated USD 5.9 million to finance eight medical research projects focused on developing innovative stem cell treatments for incurable diseases like leukemia, Parkinson's disease, and epilepsy. While the market offers substantial growth potential, certain challenges exist. Expensive procedures, regulatory complexities, and ethical considerations pose obstacles to market development. Despite these hindrances, the overall outlook for the global stem cell market remains optimistic, driven by the increasing demand for stem cell therapies, ongoing research and development efforts, and government support. As the market continues to evolve, businesses operating in the stem cell sector have the opportunity to capitalize on emerging trends and innovations, ultimately contributing to the advancement of healthcare and the betterment of patients' lives.
Stem cell research is a rapidly growing field that has the potential to revolutionize the treatment of various diseases and conditions. The market for stem cell research is expected to experience significant growth in the coming years due to factors such as the increasing prevalence of chronic diseases, rising investments in research and development, and growing demand for regenerative medicine. Additionally, technological advancements and the development of innovative stem cell therapies are expected to drive market growth. The market is highly competitive, with major players focusing on partnerships, collaborations, and mergers and acquisitions to expand their market presence. However, ethical concerns related to the use of stem cells and the high cost of stem cell therapies are expected to restrain market growth.
US Stem Cell Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Fastest Growth
adult stem cells
Growth Rate
11.4% CAGR
Global Stem Cell Market ($ Bn)
Country Share for North America (%)
To get more reports on the above market click here to Buy The Report
Stem Cell Market Segmental Analysis
Global Stem Cell Market is segmented on the basis of product, technology application, therapy, end user, and region. By product, the market is segmented into adult stem cells (ASCs), human embryonic stem cells (HESCs), induced pluripotent stem cells (iPSCs), and very small embryonic like stem cells. By technology, the market is segmented into cell acquisition, cell production, cryopreservation, and expansion & sub-culture. By application, the market is segmented into regenerative medicine and drug discovery & development. By therapy, the market is segmented into autologous and allogeneic. By end user, the market is segmented into pharmaceutical & biotechnology companies, hospitals & cell banks, and academic & research institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Stem Cell Market Analysis By Product
In 2022, adult stem cells accounted for the largest market share of the global stem cell market. One of the key reasons for their dominance is that adult stem cells do not require the destruction of embryos, unlike embryonic stem cells. Additionally, adult stem cells offer the advantage of no risk of graft rejection. The development of cell banking services, advancements in bio preservation and cryopreservation techniques, and the lower ethical concerns associated with adult cells contribute to the growth of this segment. Furthermore, the benefits of adult stem cell banking, such as autologous transformation capabilities, reduced risk of tumor formation, and the availability of established treatment options, are expected to drive the segment's growth in the forecast period. Within adult stem cells, subtypes such as Mesenchymal Stem Cells (MSCs), hematopoietic stem cells, epithelial/skin stem cells, and neural stem cells contribute to the market. Among these, MSCs are projected to exhibit the highest compound annual growth rate (CAGR) due to their use in autologous transplantation, extensive clinical trials demonstrating their efficacy in treating various diseases, and ongoing research exploring their therapeutic applications.
On the other hand, the induced pluripotent stem cells (iPSCs) segment is expected to witness the fastest CAGR from 2023 to 2030. This growth can be attributed to increased investments in regenerative medicine using iPSCs, their reproducibility and maintenance advantages, their ability to differentiate into all cell types, and their high proliferative capacity. Leading companies are also expanding their services related to iPSCs, recognizing their growing significance in disease treatment. For instance, in January 2021, REPROCELL launched a personalized induced pluripotent stem cell production service, enabling the generation and storage of patient-specific iPSCs for the development of regenerative medicines in the future. These iPSCs are developed from mature cells using readily available RNA reprogramming technology.
Stem Cell Market Analysis By Therapy
In terms of revenue generation, the allogenic therapy segment dominated the market with a significant market share in 2022. This growth can be attributed to factors such as the higher pricing of allogenic therapies and the growth of stem cell banking services. Moreover, many cell therapy companies are shifting their focus toward the development of allogeneic cell therapy products, further fueling the growth of this segment. Strategic activities undertaken by key market players to enhance their product portfolios are also expected to create lucrative opportunities in the coming years. For example, Acepodia announced the successful closure of its USD 47 million Series B financing in March 2021, aimed at advancing its pipeline of allogenic cell therapy candidates. Additionally, in June 2022, Immatics and Bristol Myers Squibb expanded their strategic alliance for the development of gamma delta allogeneic cell therapy programs.
On the other hand, the autologous therapy segment is expected to experience lucrative growth throughout the forecast period. This can be primarily attributed to the lower risk of complications associated with autologous treatments. Other factors that are anticipated to drive the growth of this segment include affordability, improved patient survival rates, elimination of the need to identify an HLA-matched donor, and the absence of graft-versus-host diseases. Moreover, autologous Mesenchymal Stem Cells (MSCs) are being investigated for their potential in treating conditions such as osteoarthritis, as they possess the ability to differentiate into cartilage and bone tissues. MSCs also exhibit the capability to migrate to the site of injury, promoting tissue repair through the release of anabolic cytokines, inhibiting pro-inflammatory pathways, and differentiating into specialized connective tissues. As a result, the adoption of autologous MSCs in regenerative medicine has witnessed a surge, driving the market's growth during the forecast period.
Global Stem Cell Market on the basis of product ($ Bn)
To get detailed analysis on other segments, Request For Free Sample Report
Stem Cell Market Regional Insights
In terms of revenue, North America emerged as the leading market, capturing a substantial share in 2022. This can be attributed to the presence of innovators and key market players in the region, resulting in higher market penetration. The strong biotechnology industry, the presence of key players, extensive research and development activities, and the promotion of personalized medicines contribute to North America's market leadership. Additionally, the region benefits from government initiatives aimed at promoting stem cell therapies. For example, the government of Canada invested approximately USD 7 million in regenerative medicine and stem cell research in March 2020. This investment supports various transnational projects and clinical trials within the country, fostering the growth of the regenerative medicine sector.
Asia Pacific is expected to exhibit rapid growth, with the fastest CAGR during the period of 2023 to 2030. This growth can be attributed to the region's strong product pipelines of stem cell-based therapies and its large patient population base. The increasing incidence rates of diseases such as cancer, neurological disorders, and diabetes contribute to the rapid growth of the stem cell market in the region. Furthermore, governments in the Asia Pacific are providing funding to accelerate research on stem cells, further bolstering market growth. For instance, in February 2022, the government of India established state-of-the-art stem cell research facilities in 40 leading health research and educational institutions. Moreover, the government has allocated USD 80 million through the Indian Council of Medical Research (ICMR) over the past three years for specific research projects. These investments and initiatives are expected to drive the growth of the stem cell market in the Asia Pacific.
Global Stem Cell Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Stem Cell Market Dynamics
Stem Cell Market Drivers
Increasing Prevalence of Chronic Diseases
- The rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is driving the demand for stem cell therapy. Stem cell transplant, stem cell injection, and stem cell treatment are increasingly being used as therapeutic options for these diseases. For instance, stem cell therapy for knees has gained popularity as a non-surgical option for treating knee pain caused by osteoarthritis. This increasing demand for stem cell therapy is expected to drive the growth of the global stem cell market.
Advancements in Stem Cell Technologies
- The development of innovative stem cell technologies is driving the growth of the global stem cell market. Advances in stem cell research and technology have led to the development of new therapies and treatments, including stem cell transplant, stem cell injection, and stem cell treatment. For instance, the use of induced pluripotent stem cells (iPSCs) has opened up new possibilities for regenerative medicine and drug discovery. Additionally, the development of 3D bioprinting technology has enabled the creation of complex tissues and organs using stem cells. These advancements in stem cell technologies are expected to drive the growth of the global stem cell market in the coming years.
Stem Cell Market Restraint
High Cost
- One of the major restraints of the global stem cell market is the high cost associated with stem cell therapies, including stem cell transplant, stem cell injection, and stem cell treatment. The high cost of these therapies is limiting their adoption, particularly in developing countries. Many patients are unable to afford these treatments, which is limiting the market's growth potential.
Regulatory Challenges
- The global stem cell market is also facing regulatory challenges, particularly in the case of stem cell research and therapy. The use of embryonic stem cells in research and therapy has been a topic of ethical debate, leading to restrictions on their use in many countries. This has limited the development of stem cell technologies and therapies. Additionally, the lack of clear regulatory guidelines for stem cell therapy has created uncertainty among patients and healthcare providers, which is hindering the market's growth potential.
Request Free Customization of this report to help us to meet your business objectives.
Stem Cell Market Competitive Landscape
The global stem cell market features a highly competitive landscape with the presence of numerous key players striving to gain a significant market share. These players are actively engaged in strategic initiatives such as mergers and acquisitions, partnerships, collaborations, and product launches to strengthen their position in the market. The prominent players in the market focus on expanding their product portfolios, investing in research and development activities, and leveraging advanced technologies to develop innovative stem cell therapies. Moreover, partnerships and collaborations with research institutions and healthcare organizations are key strategies employed by market players to accelerate the development and commercialization of stem cell-based therapies.
Top Players in the Global Stem Cell Market
- Thermo Fisher Scientific (US)
- Merck KGaA (Germany)
- Lonza Group (Switzerland)
- STEMCELL Technologies (Canada)
- Takara Bio (Japan)
- FUJIFILM Cellular Dynamics (US)
- Sartorius AG (Germany)
- GE Healthcare (UK)
- Charles River Laboratories International (US)
- Cynata Therapeutics (Australia)
- Mesoblast (Australia)
- Cellular Dynamics International (US)
- Organogenesis (US)
- Osiris Therapeutics (US)
- Gamida Cell (Israel)
- Pluristem Therapeutics (Israel)
- Athersys (US)
- Brainstorm Cell Therapeutics (Israel)
- Cellectis (France)
- Ncardia AG (Germany)
Stem Cell Market Recent Developments
- In April 2022, Aspen Neuroscience, Inc. initiated a groundbreaking patient screening study in collaboration with multiple clinical screening sites across the United States. The study, known as the Trial-Ready Cohort Study, represents an important initial phase toward submitting an Investigational New Drug (IND) application to the United States Food & Drug Administration. Aspen Neuroscience aims to investigate the potential of ANPD001, an iPSC-derived cell replacement therapy, for the treatment of Parkinson's disease.
- In April 2022, TreeFrog Therapeutics launched The Stem Cell SpaceShot Grant. This grant program provides USD 100,000 in research funding specifically focused on advancing the field of stem cell biology and regenerative medicine. The initiative aims to support innovative research projects in these areas, fostering advancements and breakthroughs in the understanding and application of stem cells.
Stem Cell Key Market Trends
- Growing Focus on Personalized Medicine: Personalized medicine is a growing trend in the global stem cell market. Stem cell therapy for knees and other conditions is increasingly being personalized to meet the unique needs of individual patients. This involves the use of patient-specific stem cells to develop personalized treatments that are tailored to the patient's genetic makeup and medical history. This trend is being driven by advancements in stem cell research and technology, which are enabling the development of personalized stem cell therapies.
- Rising Investments in Research and Development: The global stem cell market is witnessing a trend of increasing investments in research and development. Stem cell research and therapy are being viewed as a promising area of medical research, with significant potential for the development of new therapies and treatments. As a result, governments, academic institutions, and private companies are investing heavily in stem cell research and development. This trend is expected to drive the growth of the global stem cell market in the coming years, as new therapies and treatments are developed using stem cell transplant, stem cell injection, and stem cell treatment.
Stem Cell Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global Stem Cell market analyses, the global stem cell market is poised for substantial growth in the coming years. Factors driving this growth include the increasing prevalence of chronic diseases, rising investments in research and development activities, and growing applications of stem cell therapies across various medical fields. The market analysis suggests that the regenerative medicine segment, which includes stem cell therapies, holds immense potential for revolutionizing healthcare by offering innovative treatment options. Additionally, advancements in stem cell manufacturing techniques and the development of novel therapies using induced pluripotent stem cells (iPSCs) are expected to further fuel market growth. However, challenges such as ethical concerns regarding embryonic stem cells and complex regulatory frameworks need to be addressed to fully capitalize on the market's potential.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 11.83 Billion |
| Market size value in 2031 | USD 31.60 Billion |
| Growth Rate | 11.4% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
| Historical Year | 2019 |
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Stem Cell Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Stem Cell Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Stem Cell Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Stem Cell Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Stem Cell Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Stem Cell Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
